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Abstract
Integrin αIIbβ3 plays a central role in the adhesion and aggregation of platelets and thus is
essential for hemostasis and thrombosis. Integrin activation requires the transmission of a
signal from the small cytoplasmic tails of the α or β subunit to the large extracellular domains
resulting in conformational changes of the extracellular domains to enable ligand binding.
Hydrogen peroxide-inducible clone-5 (Hic-5), a member of the paxillin family, serves as a
focal adhesion adaptor protein associated with αIIbβ3 at its cytoplasmic tails. Previous stud-
ies suggested Hic-5 as a novel regulator of integrin αIIbβ3 activation and platelet aggrega-
tion in mice. To assess this in more detail, we generated Hic-5-nullmice and analyzed
activation and aggregation of their platelets in vitro and in vivo. Surprisingly, lack of Hic-5
had no detectable effect on platelet integrin activation and function in vitro and in vivo under
all tested conditions. These results indicate that Hic-5 is dispensable for integrin αIIbβ3 acti-
vation and consequently for arterial thrombosis and hemostasis in mice.
Introduction
Vessel wall injury results in the exposure of the subendothelial extracellular matrix which
initiates stable platelet adhesion and aggregation [1,2]. These processes are crucial for normal
hemostasis, but in diseased vessels they may lead to pathological thrombus formation and
infarction of vital organs [3]. Platelet adhesion and aggregation are mediated by integrins,
heterodimeric transmembrane receptors composed of α and β subunits that are expressed in a
low affinity state under resting conditions. The major platelet integrin αIIbβ3 is present in
high copy numbers (up to 100,000 per platelet) and its function is well characterized. Integrin
αIIbβ3 binds several ligands each containing an arginine-glycine-aspartic acid (RGD)
sequence, such as fibrinogen, fibrin, vWF, fibronectin, thrombospondin and vitronectin [3].
After activation mediated by other platelet receptors, integrins shift to a high affinity state and
efficiently bind their ligands [4]. This process requires the transmission of signals from the
small cytoplasmic tails to the large extracellular domains of the integrin subunits [5]. Several
proteins, including talin and kindlin-3, have been proposed to be involved in regulation of
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integrin activation [6–12]. A functional role for these proteins in integrin activation in vivo
could not be confirmed in all cases as, for example, in the case of RIAM [13]. Recently, Kim-
Kaneyama and colleagues reported that hydrogen peroxide-induced clone-5 (Hic-5) acts as a
novel regulatory factor for integrin αIIbβ3 activation and platelet aggregation in mice [14].
Hic-5 was identified as a gene inducible by transforming growth factor β1 (TGFβ1) as well as
hydrogen peroxide in a differential screen of cDNA libraries from the mouse osteoblastic cell
line MC3T3-E1. The authors of that study speculated that Hic-5 has a role in the growth-inhib-
itory pathway associated with in vitro senescence and that down-regulation of Hic-5 contrib-
utes to tumorigenesis [15]. Hic-5 contains four LIM domains at the C-terminus and shares
high homology with paxillin that has been shown to localize to focal adhesions and to interact
with talin in platelets [16,17]. In addition, it has been recently shown that paxillin negatively
regulates platelet signaling pathways resulting in augmented αIIbβ3 activation upon stimula-
tion of glycoprotein VI (GPVI) or G protein-coupled receptors (GPCR) [18].
We generated Hic-5-null (Tgfb1i1-/-) mice and found, in stark contrast to the study by Kim-
Kaneyama et al. [14], unaltered platelet integrin function in vitro and in vivo.
Material and Methods
Animals
Animal studies were approved by the district government of Lower Franconia (Bezirksregier-
ung Unterfranken; AZ 54/11). Tgfb1i1+/- mice were generated by injection of embryonic stem
cell clone EPD0817_1_D04 (KOMP) into blastocysts of pseudo-pregnant C57BL/6 females
to generate germ line chimeras. Male chimeras were bred to C57BL/6 females to generate
Tgfb1i1+/– mice, which were intercrossed to produce Tgfb1i1–/– mice and littermate wild-type
controls. Mice were genotyped by PCR, with 5’ GGGACGGGGCGTAGATAAAG 3’ and 5’
GTGCAGCCCAGATTGTCTCT 3’ for the wild-type, and 5’ TAGATAGAGATGGCGCAACG
3’ and 5’ ACACCCATTCACACACTGGA 3’ for theHic-5-null allele.
Chemicals and antibodies
Midazolam (Roche Pharma AG), fentanyl (Janssen-Cilag GmbH) and the antagonists atipame-
zol (Pfizer), flumazenil and naloxone (both from Delta Select GmbH) were used according to
the regulation of the local authorities. ADP, human fibrinogen, indomethacin and polyclonal
anti-GAPDH antibody (Antibody ID: AB_796208) were from Sigma-Aldrich (Schnelldorf,
Germany). Fibrillar type I collagen (Horm) was from Nycomed (Munich, Germany). Integrilin
was from GlaxoSmithKline (Munich, Germany). U46619 was from Enzo Life Sciences GmbH
(Lörrach, Germany), thrombin was from Roche (Mannheim, Germany), apyrase type III was
from GE Healthcare (Chalfont St. Giles, UK), low-molecular-weight heparin was from ratio-
pharm GmbH (Ulm, Germany). Monoclonal anti-Hic5 antibody (Antibody ID: AB_398703)
and monoclonal anti-CD29 antibody (Antibody ID: AB_393729) were from BD Biosciences
(Heidelberg, Germany). Polyclonal anti-paxillin antibody (Antibody ID: AB_315576) was
from Biolegend (Fell, Germany), polyclonal anti-leupaxin antibody (clone: RB37022) was
from Biorbyt (Cambridge, United Kingdom). Polyclonal anti-vWF antibody (Antibody_
ID: AB_2315604) and polyclonal rabbit anti-mouse IgG–horse-radish peroxidase (HRP)
(P026002) were from Dako Cytomation (Hamburg, Germany). Anti-rabbit IgG-HRP (Antibo-
dy_ID: AB_2099233) was from Cell Signaling (Frankfurt, Germany). All monoclonal anti-
platelet glycoprotein antibodies (host: rat), unconjugated or conjugated with fluorescein
isothiocyanate (FITC), phycoerythrin (PE), DyLight 488 or HRP were obtained from EMFRET
Analytics (Eibelstadt, Germany). Collagen-related peptide (CRP) was generated as previously
described [19].
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RT-PCR analysis
Murine platelet mRNA was isolated with Trizol reagent, reverse transcribed and detected by
RT-PCR, according to the manufacturer’s protocol (Invitrogen, Karlsruhe, Germany). The fol-
lowing primers were used to detect theHic-5 transcript: 5’ TTTTGGCCGCTGCCTTTAAC 3’
and 5’ AGGCTTGCATACTGTGCTGT 3’.
Immunoblotting
Proteins of lysed platelets were separated by SDS-PAGE and blotted onto polyvinylidene
difluoride membranes. After blocking, the membrane was incubated with antibody overnight
at 4°C. HRP-conjugated antibodies were incubated for 1 h at room temperature, and enhanced
chemilumincescence was used for visualization.
Platelet preparation, aggregation and flow cytometry
Washed platelets were prepared as described previously [20]. For aggregometry, washed plate-
lets (160 μL with 1.5x108 platelets mL-1) were analyzed in the presence (CRP) or absence
(thrombin) of 70 μg mL-1 human fibrinogen. Light transmission was recorded on a four-chan-
nel aggregometer (Fibrintimer; APACT, Hamburg, Germany) for 10 min and expressed in
arbitrary units, with buffer representing 100% light transmission. For flow cytometry, heparin-
ized whole blood was diluted 1:20 in Tyrode’s-HEPES buffer, incubated with saturating
amounts of fluorophore-conjugated mAbs for 15 min at room temperature, and analyzed on a
FACSCalibur (BD Biosciences, Heidelberg, Germany).
Adhesion under flow conditions to collagen or vWF
For adhesion to collagen, cover slips were coated with 100 μg mL-1 collagen I at 37°C o/n. For
adhesion to vWF, cover slips were coated with rabbit anti-human vWF antibody at 4°C o/n,
washed with PBS, blocked for 1 h with 1% BSA in H2O and incubated with 100 μl murine
serum obtained from control mice.
Blood (700 μl) was collected into 300 μl heparin (20 U/ml in TBS, pH 7.3). Whole blood was
diluted 2:1 in Tyrode’s buffer containing Ca2+ and filled into a 1 ml syringe. For adhesion to
collagen, before perfusion, anticoagulated blood was incubated with Dylight-488–conjugated
anti- GPIX derivative (0.2 μg/mL) at 37°C for 5 minutes.
Transparent flow chambers with a slit depth of 50 μm, equipped with the coated coverslips,
were connected to a syringe that was filled with diluted whole blood. Perfusion was performed
using a pulse-free pump under high shear stress equivalent to a wall shear rate of 1000 s-1 (col-
lagen I) or 1,700 s-1 (vWF).
Aggregate formation was visualized with a Zeiss Axiovert 200 inverted microscope (40x/
0.60 objective). Phase-contrast and fluorescence pictures were recorded with a CoolSNAP-EZ
camera, and analyzed off-line using MetaVue software.
Adhesion of platelets to bound vWF started 90 sec after perfusion of the slide. Thereafter,
cover slipes were washed by a 4 min perfusion with Tyrode’s buffer at the same shear rate and
phase-contrast images were recorded from at least five different microscopic fields (40x/0.60
objective). Image analysis was performed off-line using MetaVue software.
Platelet spreading on fibrinogen
Cover slips were coated with 100 μg mL-1 human fibrinogen and blocked with 1% BSA in PBS.
After rinsing with Tyrode-HEPES buffer, washed platelets (100 μL with 0.03x106 platelets μL-1)
were either activated with 0.01 U mL-1 thrombin or incubated with the inhibitors apyrase
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(ATP scavenger; 2U/ml) and indomethacin (inhibitor of COX-1/2; 1.4 μM) and allowed to
spread on the cover slips. At the indicated time points, platelets were fixed with PBS 4% PFA
and platelets were visualized with a Zeiss Axiovert 200 inverted microscope (100x/1.4 oil objec-
tive). Digital images were recorded using a CoolSNAP-EZ camera (Visitron) and analyzed off-
line using MetaVue software.
Platelet spreading on vWF
Glass coverslips were coated with a polyclonal rabbit anti-human vWF antibody at 4°C o/n,
washed with PBS, blocked for 1 h with 1% BSA in H2O and incubated with 100 μl murine
serum obtained from control mice. Washed platelets at 0.3x106 platelets/μl were diluted 1:2.3
in Tyrode’s with Ca2+, incubated with integrilin (40 μg/ml) and botrocetin (2 μg/ml) and were
allowed to adhere on the prepared cover slips. At the indicated time points, platelets were fixed
with PBS 4% PFA and platelets were visualized with a Zeiss Axiovert 200 inverted microscope
(100x/1.4 oil objective). Digital images were recorded using a CoolSNAP-EZ camera (Visitron)
and analyzed off-line using MetaVue software.
Clot retraction
Clot retraction studies were performed at 37°C in an aggregometer tube containing diluted
PRP (platelet rich plasma) (3×105 platelets μL-1), thrombin (5 U mL-1), and CaCl2 (20 mmol
L-1). Clot retraction was recorded with a digital camera over a time span of 4.5 hours after
activation.
Intravital microscopy of thrombus formation in FeCl3-injured mesenteric
arterioles
Four-week-old mice were anesthetized, and the mesentery was exteriorized through a midline
abdominal incision [21]. Arterioles (35–60 μm diameter) were visualized with a Zeiss Axiovert
200 inverted microscope (10x /0.3 NA objective) (CarlZeiss, Göttingen, Germany) equipped
with a 100-W HBO fluorescent lamp source, and a CoolSNAP-EZ camera (Visitron). Digital
images were recorded and analyzed off-line with MetaVue software. Injury was induced by top-
ical application of a 3 mm2 filter paper saturated with FeCl3 (20%). Adhesion and aggregation
of fluorescently labeled platelets (DyLight-488-conjugated anti-GPIX IgG-derivative) in arteri-
oles were monitored for 40 min or until complete occlusion occurred (blood flow stopped
for> 1 min).
Bleeding time
Mice were anesthetized, and a 1 mm segment of the tail tip was removed with a scalpel. Tail
bleeding was monitored by gently absorbing blood with filter paper at 20 s intervals without
making contact with the wound site. When no blood was observed on the paper, bleeding was
determined to have ceased. Experiments were stopped after 20 min. For the saline model,
1 mm of the tail tip was amputated, and the tails were immersed in 0.9% isotonic saline at
37°C. The time to complete arrest of bleeding (no blood flow for 1 minute) was determined.
Data analysis
The presented results are mean ± SD from three independent experiments per group, if not
otherwise stated. Differences between control and Hic-5-null mice were statistically analyzed
using the Mann-Whitney U-test. P-values< 0.05 were considered statistically significant.
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Results and Discussion
We used embryonic stem cells (clone EPD0817_1_D04) provided by CSD, a collaborative team
at the Children's Hospital Oakland Research Institute, and the University of California at
Davis, within the Knockout Mouse Program (KOMP) with a knockout first approach targeting
exon 1 of the Tgfb1i1 gene leading to efficient loss of Hic-5 protein in Tgfb1i1+/- mice. Tgfb1i1+-
/- mice were intercrossed to obtain Tgfb1i1-/- mice (further referred to as Hic-5-null mice) and
the respective control mice. Hic-5-null mice were born at normal Mendelian ratio, were viable
and fertile and appeared overall healthy. The absence of Hic-5 in platelets was confirmed by
Western blot analysis (Fig 1A) and RT-PCR (S1 Fig). The expression levels of the other paxillin
family members leupaxin and paxillin were unaltered in Hic-5-null platelets compared to wild-
type platelets (Fig 1A). The loss of Hic-5 did not alter platelet count or size and also red and
white blood cell counts were indistinguishable from controls (Table 1). Flow cytometric mea-
surements of major platelet surface receptors did not show significant alterations in receptor
expression levels (Table 2) in Hic-5-null platelets compared to wild-type platelets. The unal-
tered basic blood and platelet parameters in the mutant mice indicate that Hic-5 plays no role
for hematopoiesis and platelet morphology, in line with previous results of Kim-Kaneyama
et al. [14].
To clarify the role of Hic-5 deficiency on integrin activation and degranulation, activation
of the major platelet integrin αIIbβ3 and surface exposure of α-granular P-selectin in response
to different agonists was analyzed by flow cytometry. Stimulation of G-protein coupled recep-
tors with ADP, U46619, a combination of both, or thrombin resulted in comparable results for
wild-type and Hic-5-null platelets (Fig 1C and 1D). Similarly, Hic-5-null platelets reacted nor-
mally upon activation of the GPVI-ITAM (immunoreceptor tyrosine-based activation motif)
pathway by CRP and in response to stimulation of the hemITAM receptor CLEC-2 (C-type
lectin-like receptor 2) by rhodocytin (Fig 1C and 1D). β1-integrin activation was assessed by
Fig 1. Hic-5 deficiency has no effects on inside-out activation of platelet integrins, degranulation and platelet aggregation. (A) Hic-5, leupaxin and
paxillin expression was assessed byWestern blot analysis. GAPDH served as loading control. (B) Flow cytometric analysis of β1 integrin activation
(9EG7-FITC). (C, D) Flow cytometric analyses of (C) αIIbβ3 integrin activation (JON/A–phycoerythrin [PE]) and (D) degranulation-dependent P-selectin
exposure in response to the indicated agonists. Results are mean fluorescence intensity (MFI) ± standard deviation (SD) of five mice per group. (E) Washed
platelets were stimulated with the indicated agonists, and light transmission was recorded using a four channel aggregometer. Representative aggregation
curves of three individual experiments are shown. CRP, collagen-related peptide, FITC, fluorescein isothiocyanate; Thr., Thrombin; RC, rhodocytin; U46,
U46619; WT, wild-type.
doi:10.1371/journal.pone.0133429.g001
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flow cytometry using the 9EG7-antibody, which selectively binds to the activated conformation
of β1-integrins [22], and found to be indistinguishable between Hic-5-null and wild-type plate-
lets (Fig 1B). In addition, standard aggregometry was performed, but no effects of Hic-5-defi-
ciency on the aggregation response could be observed upon stimulation with any of the tested
agonists (Fig 1E). In line with the previous data, Hic-5-null platelets showed normal adhesion
(Fig 2A) and aggregate formation (Fig 2B) on collagen in a flow adhesion assay. These pro-
cesses are strongly dependent on functional GPVI and α2β1 integrins [6,8].
These results demonstrate that Hic-5 is dispensable for platelet integrin activation down-
stream of both G protein–coupled receptors and for (hem)ITAM receptors. Notably, the unal-
tered integrin αIIbβ3 activation stands in contrast to the results of Kim-Kaneyama et al. [14],
who found impaired integrin αIIbβ3 activation and reduced aggregation of Hic-5-null platelets
in response to thrombin. In line with our study, Kim-Kaneyama et al. observed unaltered plate-
let degranulation in Hic-5-deficient platelets [14].
Ligand-occupied integrin αIIbβ3 mediates outside-in signaling, leading to cytoskeletal reor-
ganization and platelet spreading [23]. Kim-Kaneyama et al. reported reduced filopodia length
in Hic-5-deficient platelets [14]. In our experimental settings, Hic-5-null and wild-type plate-
lets were allowed to spread on a fibrinogen-coated surface in the presence or absence of low
concentrations of thrombin and found to form filopodia and lamellipodia with similar kinetics,
and after 30 minutes, the number of fully spread platelets was comparable between both groups
(Fig 2C and 2D and S2 Fig). Moreover, we did not observe differences in filopodia length. To
further assess integrin outside-in signaling, we analyzed clot retraction [24] and found no dif-
ferences in the kinetics and extent of this response between wild-type and Hic-5-null mice (Fig
2E and 2F). Together, these data exclude a major role of Hic-5 for integrin αIIbβ3 outside-in
signaling in mouse platelets.
Table 1. Basic blood and platelet parameters. Platelet count and size, as well as white blood cell count and red blood cell count were analyzed using a
blood cell counter. P 0.05, n.s. WT, wild-type.
WT Hic-5-null P
Platelets μL-1 [x106] 0.94 ± 0.13 0.93 ± 0.14 n.s.
Platelet volume [fL] 5.48 ± 0.15 5.63 ± 0.05 n.s.
White blood cells μL-1 [x103] 11.52 ± 2.44 11.20 ± 1.26 n.s.
Red blood cells μL-1 [x106] 7.23 ± 0.12 7.52 ± 0.48 n.s.
doi:10.1371/journal.pone.0133429.t001
Table 2. Surface expression levels of platelet glycoproteins in wild-type and Hic-5-null mice. Expres-
sion of glycoproteins on the platelet surface was determined by flow cytometry. Diluted whole blood from the
indicated mice was incubated with FITC-labeled antibodies at saturating concentrations for 15 minutes at
room temperature, and platelets were analyzed directly. Data are expressed as mean fluorescence
intensity ± SD. P 0.05, n.s. WT, wild-type; CLEC-2, C-type lectin-like receptor 2.
WT Hic-5-null P
GPV 215 ± 6 218 ± 3 n.s.
GPIb 184 ± 4 192 ± 6 n.s.
GPIX 351 ± 16 354 ± 8 n.s.
GPVI 38 ± 2 37 ± 1 n.s.
αIIbβ3 420 ± 23 434 ± 17 n.s.
α2 44 ± 2 47 ± 7 n.s.
β1 117 ± 4 118 ± 3 n.s.
CD9 810 ± 14 781 ± 42 n.s.
CLEC-2 105 ± 3 106 ± 4 n.s.
doi:10.1371/journal.pone.0133429.t002
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At sites of vascular injury, vWF is exposed on the subendothelial extracellular matrix
(ECM). The interaction between the platelet GPIb-V-IX receptor complex and vWF is impor-
tant for platelet tethering, the initial step during the formation of a hemostatic plug. A potential
role of Hic-5 in GPIb-mediated processes was assessed by monitoring the adhesion of platelets
on immobilized vWF under high shear conditions. Hic-5-null and wild-type platelets attached
to the immobilized vWF and in part firmly adhered to the surface to comparable extent and
with similar kinetics (Fig 3A). In addition, we analyzed platelet spreading on a vWF-coated
matrix under conditions of αIIbβ3 integrin-blockade. The stimulation of platelets by a GPIb
specific signal results in a shape change, which is limited to contraction of the cell body and
filopodia formation [25]. Both, Hic-5-null and wild-type platelets extended comparable num-
bers of filopodia (Fig 3B). Together, these results indicate that GPIb function is intact in Hic-
5-deficient platelets.
To investigate the role of Hic-5 in platelet function in vivo, we utilized two widely used tail
bleeding time assays (filter paper and warm saline) and found comparable bleeding times for
control and Hic-5-null mice (Fig 4A and S3 Fig respectively). This result stands in contrast to
the study of Kim-Kaneyama et al. who found prolonged bleeding times in Hic-5-null mice
using the saline method [14].
Kim-Kaneyama et al. reported that Hic-5-null mice are more resistant to experimental
thromboembolism than control mice [14]. Consistent with our in vitro results, pathological
thrombus formation, as assessed by intravital microscopy of FeCl3-injured mesenteric arteri-
oles, was indistinguishable between wild-type and Hic-5-null mice, resulting in similar
Fig 2. Lack of Hic-5 has no influence on platelet adhesion to collagen, spreading on fibrinogen and platelet integrin outside-in signaling in vitro. (A,
B) Adhesion (A) and thrombus formation (B) of platelets on collagen was assessed in a flow adhesion assay at a wall shear rate of 1000 s-1. Scale bar,
25 μm. (C, D) Washed platelets of WT and Hic-5-null mice were allowed to spread on fibrinogen for up to 30 minutes after stimulation with 0.01 U mL-1
thrombin. (C) Representative images and (D) statistical evaluation of the percentage of spread platelets at different spreading stages are shown. Scale bar,
5 μm. (E, F) Clot formation in platelet-rich plasma was induced by the addition of thrombin (5 U mL-1) and 20 mmol L-1 CaCl2 and clot retraction was
monitored over time (E). (F) Residual volume of serum after clot retraction was measured.
doi:10.1371/journal.pone.0133429.g002
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occlusion times for both groups (Fig 4B and 4C). These data indicate a dispensable role of
Hic-5 in thrombus formation in vivo.
In this study, constitutive knockout mice for Hic-5 were used to assess the role of this focal
adhesion protein in platelet function in vitro and in vivo. We did not detect any alterations in
integrin inside-out or outside-in signaling in the absence of Hic-5, arguing against an essential
role of the adaptor in these processes. Consequently, hemostasis and experimental thrombus
formation were not affected by the lack of Hic-5. It is difficult to explain the discrepancy
between our study and that of Kim-Kaneyama et al. [14], but differences in the genetic back-
ground might contribute, as previously proposed as a possible explanation for differences
observed in the phenotype of GPVI-deficient mice [26]. However, based on our results we sup-
pose that Hic-5 plays only a minor role in platelet integrin signaling in vitro and in vivo. Pre-
sumably, Hic-5 deficiency can be compensated by the other paxillin family members, paxillin
and leupaxin, which are both expressed in murine platelets [27]. This is supported by a study
from Rathore and colleagues [27]. They could show, that in aggregating human platelets, Hic-
5 was tyrosine phosphorylated and recruited Csk (C-terminal Src kinase) via its SH2 domains
to regulate SFK (Src family kinases) activity. However, in aggregating mouse platelets, Csk
bound preferentilly to paxillin instead of Hic-5, although both are abundantly expressed.
It is possible that Hic-5 and the other paxillin family members share some tissue specific
functions and that Hic-5 could play important roles in cells or tissues other than platelets. As
an example, Hic-5 has been shown to have a role in the development of abdominal aortic aneu-
rysms [28].
Notably, however, in contrast to mouse platelets human platelets express Hic-5 as the only
paxillin family member [27]. Under these conditions, loss of Hic-5 could exert effects on
Fig 3. Hic-5-deficient platelets have unaltered GPIb function. (A) Whole blood of wild-type and Hic-5-null
mice was perfused over a vWF-coated surface at a wall shear rate of 1,700 sec-1 and the number of adherent
platelets was quantified. (B) Washed platelets were treated with integrilin (40 μg/ml) and botrocetin (2 μg/ml)
and allowed to adhere to vWF-coated cover slips. Filopodia formation was quantified according to the number
of extensions per platelet at indicated the time points.
doi:10.1371/journal.pone.0133429.g003
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human platelet function in thrombosis and hemostasis. To investigate this in mice, a mouse
strain lacking all three paxillin members would be required.
Supporting Information
S1 Fig. Expression of Tgfb1i1mRNA. Analysis of the presence of Tgfb1i1mRNA in platelets
by RT-PCR. GAPDHmRNA served as positive control. cDNA free sample was used as nega-
tive control.
(TIF)
S2 Fig. Spreading on fibrinogen of unstimulated platelets.Washed platelets of WT and Hic-
5-null mice were allowed to spread on fibrinogen for up to 60 minutes in the presence of apy-
rase (2 U/ml) and indomethacin (1.4 μM).
(TIF)
S3 Fig. Normal hemostasis in Hic-5-null mice. Tail bleeding times in saline of wild-type and
Hic-5-null mice. Each symbol represents 1 animal.
(TIF)
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Fig 4. Unaltered in vivo thrombus formation in Hic-5-deficient mice. (A) Tail bleeding times of wild-type
and Hic-5-null mice. Each symbol represents 1 animal. (B, C) Thrombus formation in small mesenteric
arterioles was induced by topical application of 20% FeCl3. For monitoring of thrombus formation by intravital
microscopy, platelets were labeled fluorescently. Time to stable occlusion (B) and representative pictures (C)
of wild-type and Hic-5-null mice are shown. Each symbol represents one individual.
doi:10.1371/journal.pone.0133429.g004
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